Regeneron Pharmaceuticals
Utility Patents
Last updated:
List of all Regeneron Pharmaceuticals patents 248 in total
| Status | Patent |
|---|---|
Grant | Utility: Anti-ASIC1 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 24 Dec 2019 |
Grant | Utility: Human antibodies to Ebola virus glycoprotein Filling date: 12 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Humanized C5 animals Filling date: 12 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 Filling date: 12 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor Filling date: 12 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: Humanized IL-4 and IL-4R.alpha. animals Filling date: 12 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation Filling date: 12 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Stabilized formulations containing anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Rodent model of steel syndrome Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Maytansinoid derivatives, conjugates thereof, and methods of use Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Human antibodies to S. aureus Hemolysin A toxin Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Genetically modified non-human animals expressing human EPO Filling date: 12 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Efficient selectivity of recombinant proteins Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Methods of treating skin cancer by administering a PD-1 inhibitor Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Methods and compositions for targeted genetic modification using paired guide RNAs Filling date: 12 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Rodent embryonic stem cell with conditional ACVR1 mutant alleles Filling date: 12 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Anti-Tie2 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Methods of treating obesity with anti-ANGPTL8 antibodies Filling date: 12 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Humanized IL-6 and IL-6 receptor Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies Filling date: 12 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Non-human animals having a humanized signal-regulatory protein gene Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Fusion polypeptides capable of activating receptors Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Humanized Fc.gamma.R mice Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Methods and compositions for generating or maintaining pluripotent cells Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Dosing regimens for use with PCSK9 inhibitors Filling date: 12 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Anti-Zika virus antibodies and methods of use Filling date: 12 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Mice expressing a limited immunoglobulin light chain repertoire Filling date: 12 Sep 2025 Issue date: 17 Sep 2019 |
Grant | Utility: Enhanced expression and stability regions Filling date: 12 Sep 2025 Issue date: 17 Sep 2019 |
Grant | Utility: Rodent model of prostate cancer Filling date: 12 Sep 2025 Issue date: 17 Sep 2019 |
Grant | Utility: Method of manufacturing VEGF antagonist fusion proteins Filling date: 12 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Human antibodies to Middle East Respiratory Syndrome--coronavirus spike protein Filling date: 12 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A Filling date: 12 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: VEGF antagonist formulations suitable for intravitreal administration Filling date: 12 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Human antibodies to influenza hemagglutinin Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Non-human animals having a humanized programmed cell death 1 gene Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Methods and systems for copy number variant detection Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Multifunctional alleles Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Targeted modification of rat genome Filling date: 12 Sep 2025 Issue date: 20 Aug 2019 |
Grant | Utility: Human antibodies to GREM1 Filling date: 12 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus Filling date: 12 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Methods of making a nucleic acid encoding a human variable region Filling date: 12 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Methods for treating skin infection by administering an IL-4R antagonist Filling date: 12 Sep 2025 Issue date: 6 Aug 2019 |
Showing 200 to 248 of 248 patents.